Reynolds Delgado III, MD

Dr. Reynolds M. Delgado, III is a cardiologist specializing in heart failure and heart transplantation at Baylor St. Luke's Medical Center/The Texas Heart Institute. He has been a Basic Science Researcher in Heart Failure at The Texas Heart Institute, Baylor College of Medicine, and The University of Texas Houston Medical School since 1997 and has held the position of Medical Director of Mechanical Support Devices in Heart Failure at The Texas Heart Institute since 2003. His academic appointments include clinical assistant professor of medicine at Baylor College of Medicine and UT Health Science Center, Houston. He participates on numerous advisory boards, including Thoratec Corporation, Medtronic Corporation and Boston Scientific Corporation, and has been on the Medical Education Committee at The Texas Heart Institute since 2004. He is also a long-standing research collaborator with NASA Johnson Space Center Human Space Flight Physiology Laboratory. Show full bio

Dr. Delgado earned a Bachelor of Arts from The University of Texas at Austin in 1987, and a medical degree from The University of Texas Southwestern Medical School in Dallas in 1991. He completed a residency in internal medicine at The University of Texas Southwestern Medical School, and a fellowship in cardiology at The University of Texas Houston Health Science Center. Included in that fellowship program was a 15-month fellowship in heart failure and clinical cardiac transplantation at The Texas Heart Institute.

He created the heart failure clinic program at Baylor St. Luke’s Medical Center and is on the Transplant Medical Review Board there. As a result of his extensive experience in the heart failure and transplant arenas, he was one of four physicians worldwide asked to develop the Guidelines for the Care of Heart Transplant Recipients by the International Society for Heart and Lung Transplantation. He also authored “Mechanical Circulatory Support in Patients with Heart Failure,” included in the definitive textbook Health Failure: A Companion to Braunwald’s Heart Disease.

Dr. Delgado has authored or co-authored numerous articles for major scientific journals, including the New England Journal of Medicine, the Journal of Heart and Lung Transplantation, Congestive Heart Failure, and Circulation, the premier journal of the American Heart Association. He currently serves or has served on the editorial boards of The Texas Heart Institute Journal, Circulation, and the Journal of Heart and Lung Transplantation. He lectures extensively, with presentations in Mexico, Canada, Greece, France, Serbia, Slovenia, and Argentina, among other places.

See Publications

Texas Heart Institute Positions

Current Projects

Interests

  • Cardiology
  • Heart Failure

Education

  • Undergraduate:

    The University of Texas (Biology)

  • Medical School:

    The University of Texas Southwestern Medical School

  • Residency:

    The University of Texas Southwestern - Parkland Health & Hospital System

  • Fellowships:

    The University of Texas Health Science Center - Houston
    The Texas Heart Institute, Heart Failure and Cardiac Transplantation

Academic & Clinical Affiliations

  • Baylor College of Medicine
  • Baylor St. Luke's Medical Center

Certifications

  • American Board of Internal Medicine
  • Advanced Heart Failure/Transplant Cardiology

Honors, Awards and Memberships

Publications

Chou, B. P., Critsinelis, A., Lamba, H. K. et al. (2021). Continuous-flow left ventricular assist device support in patients with ischemic versus nonischemic cardiomyopathy. Tex Heart Inst J 48, e207241. https://doi.org/10.14503/THIJ-20-7241.
Parikh, V. Y., Parikh, U. M., Moctezuma-Ramirez, A. et al. (2020). Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices. Gen Thorac Cardiovasc Surg 68, 1278–1284. https://doi.org/10.1007/s11748-020-01371-w.
Letsou, G. V., Musfee, F. I., Lee, A. D. et al. (2020). Ten-year survival with a continuous-flow left ventricular assist device and aortic valve closure. Tex Heart Inst J 47, 325–328. https://doi.org/10.14503/THIJ-19-7193.
Maffei, S. R., Lamba, H. K., Mensah, C. K. et al. (2020). Plasmapheresis in patients with heparin-induced thrombocytopenia requiring ventricular assist device. Ann Thorac Surg 109, e439–e440. https://doi.org/10.1016/j.athoracsur.2019.09.056.
Critsinelis, A. C., Lamba, H. K., Nguyen, M. T. et al. (2020). Accuracy of postoperative risk scores for survival prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 continuous-flow left ventricular assist device recipients. ASAIO J 66, 539–546. https://doi.org/10.1097/MAT.0000000000001044.
Chou, B. P., Lamba, H. K., Cheema, F. H. et al. (2020). Outcomes of repeat left ventricular assist device exchange. ASAIO J 66, 64–68. https://doi.org/10.1097/MAT.0000000000000928.
Hinds, E. D., Marin, M. J., George, J. et al. (2019). A coronary cameral fistula treated with coil embolization. JRSM Cardiovasc Dis 8, 2048004019856801. https://doi.org/10.1177/2048004019856801.
Anjum, A., Kurihara, C., Critsinelis, A. et al. (2018). Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs 21, 285–292. https://doi.org/10.1007/s10047-018-1047-0.
Gohar, S., Sheth, S. and Delgado, R., III (2017). Optimization of right ventricular function preoperatively for LVAD implantation. In Mechanical Circulatory Support for Advanced Heart Failure: A Texas Heart Institute/Baylor College of Medicine Approach (35–55). https://doi.org/10.1007/978-3-319-65364-8_3.
Jabbar, A. A., Franklin, W. J., Simpson, L. et al. (2015). Improved systemic saturation after ventricular assist device implantation in a patient with decompensated dextro-transposition of the great arteries after the Fontan procedure. Tex Heart Inst J 42, 40–43. https://doi.org/10.14503/THIJ-13-3374.